| Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer SNM Nafi, D Generali, G Kramer-Marek, M Gijsen, C Strina, M Cappelletti, ... Oncotarget 5 (15), 5934, 2014 | 76 | 2014 |
| The unique biology behind the early onset of breast cancer A Siddig, TADAA Tengku Din, SN Mohd Nafi, MM Yahya, S Sulong, ... Genes 12 (3), 372, 2021 | 19 | 2021 |
| Plasma circulating mirnas profiling for identification of potential breast cancer early detection biomarkers AR Jusoh, SV Mohan, TL Ping, TADAA Bin, T Din, J Haron, RC Romli, ... Asian Pacific Journal of Cancer Prevention: APJCP 22 (5), 1375, 2021 | 16 | 2021 |
| A GNAS gene mutation’s independent expression in the growth of colorectal cancer: a systematic review and meta-analysis HA Afolabi, SM Salleh, Z Zakaria, ES Ch’ng, SN Mohd Nafi, ... Cancers 14 (22), 5480, 2022 | 14 | 2022 |
| The association between phenotype and size of breast tumors induced by 1-methyl-1-nitrosourea (MNU) injection in rats. H Jaafar, MN SN Medical Science Monitor: International Medical Journal of Experimental and …, 2009 | 13 | 2009 |
| Overexpression of DNA methyltransferase 1 (DNMT1) protein in astrocytic tumour and its correlation with O6-methylguanine-DNA methyltransferase (MGMT) expression WFWA Rahman, KS Ab Rahman, SNM Nafi, MH Fauzi, H Jaafar International journal of clinical and experimental pathology 8 (6), 6095, 2015 | 11 | 2015 |
| Andrographolide is an alternative treatment to overcome resistance in er-positive breast cancer via cholesterol biosynthesis pathway H Rajaratinam, SNM Nafi The Malaysian Journal of Medical Sciences: MJMS 26 (5), 6, 2019 | 9 | 2019 |
| Cellular and Molecular Changes in MNU-Induced Breast Tumours Injected with PF4 or bFGF SNM Nafi, F Idris, H Jaafar Asian Pacific Journal of Cancer Prevention: APJCP 18 (12), 3231, 2017 | 7 | 2017 |
| nNav1. 5 expression is associated with glutamate level in breast cancer cells II Azahar, NA Sharudin, AHM Noor Din, AT Che Has, SN Mohd Nafi, ... Biological Research 55 (1), 18, 2022 | 6 | 2022 |
| Expression of IGFBP-rP1 in ovarian and breast cancers in association with diabetes mellitus status. SN Mohd Nafi, AH Siti Azrin, AA Mat Zin, NH Othman, NA Che Jalil Malaysian Journal of Pathology 41 (1), 2019 | 4 | 2019 |
| The Prediction of Survival Outcome and Prognosis Factor in Association with Comorbidity Status in Patients with Colorectal Cancer: A Research-Based Study H Afolabi, SM Salleh, Z Zakaria, ES Ch’ng, SN Mohd Nafi, AAB Abdul Aziz, ... Healthcare 10 (9), 1693, 2022 | 3 | 2022 |
| A retrospective hospital-based study of HMGCR expression in HER2 IHC 2+ and 3+ breast cancer M Mohamed, SNM Nafi, H Jaafar, NM Paiman Asian Pacific Journal of Cancer Prevention: APJCP 22 (7), 2043, 2021 | 3 | 2021 |
| Comparing the Biology of Young versus Old Age Estrogen-Receptor-Positive Breast Cancer through Gene and Protein Expression Analyses A Siddig, WF Wan Abdul Rahman, SN Mohd Nafi, S Sulong, MM Yahya, ... Biomedicines 11 (1), 200, 2023 | 2 | 2023 |
| Colorectal cancer in patient younger than 50-year-old in Kelantan: Two case reports NAC Jalil, NH Othman, WFWA Rahman, AD Zakaria, AHZ Samsudin, ... The Malaysian Journal of Pathology 44 (2), 285-290, 2022 | 2 | 2022 |
| Endocan-microvascular Density in Primary Ovarian Carcinoma F Baba, AI Yajid, SNM Nafi, SA Ab Hamid, WNAW Adnan, NAC Jalil Asian Pacific Journal of Cancer Prevention: APJCP 23 (3), 929, 2022 | 2 | 2022 |
| The Clinicopathological Characteristics of Young-Onset Versus Adult-Onset Colorectal Cancer: A Tertiary Hospital-Based Study RI Tsamiya, SNM Nafi, NAC Jalil, AAM Zin The Malaysian Journal of Medical Sciences: MJMS 31 (1), 200, 2024 | 1 | 2024 |
| Kepentingan Bioinformatik Dalam Analisa Genomik Ke Arah Perubatan Jitu Untuk Covid-19 SNM Nafi e-Jurnal Penyelidikan dan Inovasi 11 (2), 33-42, 2024 | | 2024 |
| FOXP3+ regulatory T cells, mismatch repair proteins and BRAF V600E status in young-onset colorectal cancer RI Tsamiya, SNM Nafi, NAC Jalil, AAM Zin The Malaysian Journal of Pathology 46 (2), 233-246, 2024 | | 2024 |
| OPTIMIZATION AND VALIDATION OF FOXP3, BRAFV600E AND MMR IMMUNOHISTOCHEMISTRY STAINING PROTOCOLS RI Tsamiya, SNM Nafi, NAC Jalil, AAM Zin Jurnal Teknologi (Sciences & Engineering) 86 (4), 161-170, 2024 | | 2024 |
| Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models M Arshad, A Azad, PYK Chan, V Vigneswara, K Feldinger, SNM Nafi, ... British Journal of Cancer, 1-13, 2024 | | 2024 |
Nur Asyilla Che JalilAP DrVerified email at usm.my
Nur Asyilla Che JalilAP DrVerified email at usm.my